London
11 °C
Manchester
9 °C
Glasgow
Dublin
Belfast
9 °C
Washington
13 °C
Denver
Atlanta
Dallas
Houston Texas
New Orleans
El Paso
Phoenix
Los Angeles
15 °C
-27 °C
-8 °C
23 °C
22 °C
3 °C
Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025
NYSE - LSE
| CMSC | 0.34% | 23.5 | $ | |
| BCC | 2.23% | 106.055 | $ | |
| AZN | 1.67% | 75.955 | $ | |
| GSK | 2.45% | 38.011 | $ | |
| BCE | -0.58% | 23.94 | $ | |
| SCS | 1.68% | 12.53 | $ | |
| NGG | 0.53% | 62.52 | $ | |
| BTI | 0.74% | 38.375 | $ | |
| RIO | -2.03% | 61.49 | $ | |
| RYCEF | 0.65% | 7.72 | $ | |
| CMSD | 0.73% | 23.632 | $ | |
| RELX | 0.45% | 49.41 | $ | |
| VOD | 1.49% | 8.71 | $ | |
| JRI | 0.47% | 12.87 | $ | |
| RBGPF | 0.87% | 65.42 | $ | |
| BP | -1.46% | 33.254 | $ |
Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025
CAMBRIDGE, MA / ACCESS Newswire / January 29, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 14, 2025 to report its fourth quarter and full year 2024 financial results, and provide a corporate update.
A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.
Webcast: https://investors.modernatx.com
The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Media Contacts
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
N.Mahnke--BlnAP
